The research support services sponsored by the RCMI Program are the Molecular Biology Research Laboratory (MBRL), the Cell Culture Research Laboratory (CCRL), the Electron Microscopy Research Laboratory and Photography Center (EMRL/PC), and the Nuclear Magnetic Resonance Center (NMRC). The RCMI support for these facilities includes 50% of the salary and fringe benefits for the managers of the MBRL and CCRL, and 25% of the salary and fringe benefits of the manager of the NMRC. Given the limited amount of use of the EMRL/PC for EM work in recent years, its support by RCMI is proposed to end and the facility shut down. The confocal microscope and the slide preparation system, the pieces of equipment that have been used routinely in the EMRL, will be relocated for the convenience of the scientists. Discussions are underway with university administrators about the disposition of the EM equipment in the facility. Other support includes a minimal supply allowance for each facility to purchase disposable supplies and gases, equipment purchases (as dictated by Center scientists), and an equipment repair allowance for service of instrumentation that is not under service contract. It is proposed that the RCMI Program continue to support the three facilities named above (MBRL, CCRL, and NMRC) for the next funding cycle. The facilities have contributed significantly to the enhancement of the biomedical research infrastructure at the University and to the research productivity of RCMI-affiliated scientists by providing equipment and/or expertise not available in an individual investigator?s laboratory. These facilities have also provided training in state-of-the-art methodologies for scientists, staff and students.

Project Start
2002-09-19
Project End
2003-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
16
Fiscal Year
2002
Total Cost
$88,647
Indirect Cost
Name
Clark Atlanta University
Department
Type
DUNS #
065325177
City
Atlanta
State
GA
Country
United States
Zip Code
30314
Morton, Derrick J; Patel, Divya; Joshi, Jugal et al. (2017) ID4 regulates transcriptional activity of wild type and mutant p53 via K373 acetylation. Oncotarget 8:2536-2549
Joshi, Jugal Bharat; Patel, Divya; Morton, Derrick J et al. (2017) Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52. Mol Oncol 11:337-357
Komaragiri, Shravan Kumar; Bostanthirige, Dhanushka H; Morton, Derrick J et al. (2016) ID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells. Biochem Biophys Res Commun 478:60-66
Wilder, Catera L; Walton, Charlene; Watson, Valencia et al. (2016) Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells. Int J Biochem Cell Biol 79:199-208
Brown, Shanora G; Knowell, Ashley E; Hunt, Aisha et al. (2015) Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis. Prostate 75:266-79
Muniyan, Sakthivel; Chou, Yu-Wei; Tsai, Te-Jung et al. (2015) p66Shc longevity protein regulates the proliferation of human ovarian cancer cells. Mol Carcinog 54:618-31
Chinaranagari, Swathi; Sharma, Pankaj; Bowen, Nathan J et al. (2015) Prostate cancer epigenome. Methods Mol Biol 1238:125-40
Burton, Liza J; Smith, Basil A; Smith, Bethany N et al. (2015) Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. Carcinogenesis 36:1019-27
Goodson 3rd, William H; Lowe, Leroy; Carpenter, David O et al. (2015) Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis 36 Suppl 1:S254-96
Mandal, S; Abebe, F; Chaudhary, J (2014) -174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race. Genet Mol Res 13:139-51

Showing the most recent 10 out of 99 publications